Cypress Capital Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,278
| Closed | -$594K | – | 310 |
|
|
2024
Q3 | $594K | Sell |
1,278
-87
| -6% | -$40.5K | 0.07% | 208 |
|
|
2024
Q2 | $640K | Sell |
1,365
-740
| -35% | -$347K | 0.08% | 185 |
|
|
2024
Q1 | $880K | Sell |
2,105
-329
| -14% | -$138K | 0.11% | 164 |
|
|
2023
Q4 | $990K | Sell |
2,434
-243
| -9% | -$98.9K | 0.13% | 141 |
|
|
2023
Q3 | $931K | Sell |
2,677
-36
| -1% | -$12.5K | 0.13% | 140 |
|
|
2023
Q2 | $955K | Buy |
2,713
+821
| +43% | +$289K | 0.14% | 145 |
|
|
2023
Q1 | $596K | Sell |
1,892
-58
| -3% | -$18.3K | 0.09% | 198 |
|
|
2022
Q4 | $563K | Buy |
1,950
+649
| +50% | +$187K | 0.09% | 202 |
|
|
2022
Q3 | $377K | Buy |
1,301
+510
| +64% | +$148K | 0.06% | 210 |
|
|
2022
Q2 | $223K | Hold |
791
| – | – | 0.03% | 268 |
|
|
2022
Q1 | $207K | Sell |
791
-882
| -53% | -$231K | 0.03% | 296 |
|
|
2021
Q4 | $367K | Sell |
1,673
-1,663
| -50% | -$365K | 0.05% | 237 |
|
|
2021
Q3 | $605K | Sell |
3,336
-322
| -9% | -$58.4K | 0.08% | 194 |
|
|
2021
Q2 | $738K | Sell |
3,658
-649
| -15% | -$131K | 0.1% | 183 |
|
|
2021
Q1 | $926K | Sell |
4,307
-1,364
| -24% | -$293K | 0.13% | 150 |
|
|
2020
Q4 | $1.34M | Sell |
5,671
-1,761
| -24% | -$416K | 0.2% | 111 |
|
|
2020
Q3 | $2.02M | Buy |
7,432
+1,907
| +35% | +$519K | 0.34% | 76 |
|
|
2020
Q2 | $1.6M | Buy |
5,525
+4,567
| +477% | +$1.33M | 0.29% | 85 |
|
|
2020
Q1 | $228K | Hold |
958
| – | – | 0.05% | 185 |
|
|
2019
Q4 | $210K | Buy |
+958
| New | +$210K | 0.04% | 230 |
|